BioNTech IMFS Expands Production Capacities
Since more than 15 years we are developing and manufacturing retroviral vectors for clinical supply. Check out what we can do for you.
BioNTech IMFS supports you in the development and industrialization of your cell-based therapy product: fast, safe and efficient.
We manufacture GMP grade IVT mRNA that can be used either as a drug product for in vivo use or as starting material for ex vivo applications.